Login / Signup

Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study.

Juan Francisco Alcalá-DíazLaura Limia-PerezRicardo Gómez HuelgasMaría Dolores Martín-EscalanteBegoña Cortes-RodriguezJose L Zambrana-GarciaMarta Entrenas-CastilloAna I Perez-CaballeroMaría-Dolores López-CarmonaJavier Garcia-AlegriaAquiles Lozano Rodríguez-MancheñoMaria Del Sol Arenas-de LarrivaLuis M Pérez-BelmonteIrwin JungreisRoger BouillonJose Manual Quesada-GomezJose Lopez-Miranda
Published in: Nutrients (2021)
Among patients hospitalized with COVID-19, treatment with calcifediol, compared with those not receiving calcifediol, was significantly associated with lower in-hospital mortality during the first 30 days. The observational design and sample size may limit the interpretation of these findings.
Keyphrases
  • coronavirus disease
  • sars cov
  • emergency department
  • cardiovascular disease
  • combination therapy
  • cross sectional
  • adverse drug